Epidermal growth factor receptor mutation status in pulmonary adenocarcinoma: Multi-institutional data discussion at national conference of “Lung Cancer Management in Indian context”
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Current Problems in Cancer
- Vol. 44 (3) , 100561
Abstract
No abstract availableKeywords
Funding Information
- Lady Tata Memorial Trust
This publication has 33 references indexed in Scilit:
- Frequency of EGFR Mutations in 907 Lung Adenocarcioma Patients of Indian EthnicityPLOS ONE, 2013
- Common and Rare EGFR and KRAS Mutations in a Dutch Non-Small-Cell Lung Cancer Population and Their Clinical OutcomePLOS ONE, 2013
- EGFR Mutations in Indian Lung Cancer Patients: Clinical Correlation and Outcome to EGFR Targeted TherapyPLOS ONE, 2013
- Epidermal growth factor receptor mutation subtypes and geographical distribution among Indian non-small cell lung cancer patientsIndian Journal of Cancer, 2013
- Epidermal growth factor receptor mutation in non-small-cell lung carcinomas: A retrospective analysis of 1036 lung cancer specimens from a network of tertiary cancer care centers in IndiaIndian Journal of Cancer, 2013
- Impact of Systematic EGFR and KRAS Mutation Evaluation on Progression-Free Survival and Overall Survival in Patients with Advanced Non–Small-Cell Lung Cancer Treated by Erlotinib in a French Prospective Cohort (ERMETIC Project—Part 2)Journal of Thoracic Oncology, 2012
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancersInternational Journal of Cancer, 2006
- Mutations in the Tyrosine Kinase Domain of the Epidermal Growth Factor Receptor in Non–Small Cell Lung CancerClinical Cancer Research, 2005
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibNew England Journal of Medicine, 2004